© 1997 American Heart Association, Inc.
Articles |
HDL and ApoA Prevent Cell Death of Endothelial Cells Induced by Oxidized LDL
From the Department of Biochemistry, INSERM U.466, IFR Louis Bugnard, University Paul Sabatier, Toulouse, France.
Correspondence to Dr A. Nègre-Salvayre or Prof R. Salvayre, Laboratoire de Biochimie et INSERM U.466, C.H.U. Rangueil-1, Ave Jean Poulhès, 31403 Toulouse Cedex 4, France. E-mail salvayre{at}rangueil.inserm.fr
Abstract We have previously demonstrated that toxic doses of mildly oxidized LDL evokes in cultured cells a delayed and sustained rise of cytosolic [Ca2+], eliciting in turn irreversible cell damage and leading finally to cell death. HDL and delipidated apolipoprotein (apo) A prevented effectively the toxic effect of oxidized LDL to bovine aortic endothelial cells, in a time- and dose-dependent manner. The major part of the protective effect was mimicked by purified apoA-I, whereas purified apoA-II exhibited only very low protective activity. The protective effect was independent of the paraoxonase-linked HDL activity. The protective effect of HDL is independent of the contact of HDL with oxidized LDL, as shown by preincubation of oxidized LDL with HDL or apoA. In contrast, the protective effect was dependent on the integrity of apoA and on the contact of HDL with cells, thus suggesting that HDL acts directly on cells by enhancing their resistance against oxidized LDL. Preincubation experiments show that the protective effect is dependent on the duration of the contact of cells with HDL (maximal effect observed after 12 to 16 hours' preincubation), is also dependent on protein synthesis, and is persistent for at least 48 hours after the end of the contact of HDL with cells. Finally, effective concentrations of HDL inhibit the Ca2+ peak, which is directly involved in the cytotoxic effect of oxidized LDL, as shown by the inhibitory effect of Ca2+ chelators. All together, these results suggest that HDL, mainly apoA-I, increases the resistance of endothelial cells against oxidized LDL and prevents its toxic (apoptotic) effect by blocking the pathogenic intracellular signaling (culminating in sustained Ca2+ rise) involved in cell death.
Key Words: lipoproteins • HDL • oxidized LDL • apoA • apoptosis • toxicity • atherosclerosis
This article has been cited by other articles:
 |
|
 |
|
  C. Radojkovic, A. Genoux, V. Pons, G. Combes, H. de Jonge, E. Champagne, C. Rolland, B. Perret, X. Collet, F. Terce, et al. Stimulation of Cell Surface F1-ATPase Activity by Apolipoprotein A-I Inhibits Endothelial Cell Apoptosis and Promotes Proliferation Arterioscler. Thromb. Vasc. Biol., July 1, 2009; 29(7): 1125 - 1130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sattler and B. Levkau Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection Cardiovasc Res, May 1, 2009; 82(2): 201 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kontush, P. Therond, A. Zerrad, M. Couturier, A. Negre-Salvayre, J. A. de Souza, S. Chantepie, and M. J. Chapman Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles: Relevance to Antiapoptotic and Antioxidative Activities Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1843 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Berrougui, M. Isabelle, M. Cloutier, G. Grenier, and A. Khalil Age-related impairment of HDL-mediated cholesterol efflux J. Lipid Res., February 1, 2007; 48(2): 328 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kontush and M. J. Chapman Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Mineo, H. Deguchi, J. H. Griffin, and P. W. Shaul Endothelial and Antithrombotic Actions of HDL Circ. Res., June 9, 2006; 98(11): 1352 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Mikael, J. Genest Jr, and R. Rozen Elevated Homocysteine Reduces Apolipoprotein A-I Expression in Hyperhomocysteinemic Mice and in Males With Coronary Artery Disease Circ. Res., March 3, 2006; 98(4): 564 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Robbesyn, N. Auge, C. Vindis, A.-V. Cantero, R. Barbaras, A. Negre-Salvayre, and R. Salvayre High-Density Lipoproteins Prevent the Oxidized Low-Density Lipoprotein-Induced Endothelial Growth Factor Receptor Activation and Subsequent Matrix Metalloproteinase-2 Upregulation Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1206 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Cao, K. Murao, H. Imachi, X. Yu, H. Abe, A. Yamauchi, M. Niimi, A. Miyauchi, N. C. W. Wong, and T. Ishida A Mutant High-Density Lipoprotein Receptor Inhibits Proliferation of Human Breast Cancer Cells Cancer Res., February 15, 2004; 64(4): 1515 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Miura, M. Fujino, Y. Matsuo, A. Kawamura, H. Tanigawa, H. Nishikawa, and K. Saku High Density Lipoprotein-Induced Angiogenesis Requires the Activation of Ras/MAP Kinase in Human Coronary Artery Endothelial Cells Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 802 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Kim, Y.-K. Hong, Y. A. Joe, Y. Lee, J.-Y. Shin, H.-E. Park, I.-H. Lee, S.-Y. Lee, D.-K. Kang, S.-I. Chang, et al. Anti-angiogenic Activity of the Recombinant Kringle Domain of Urokinase and Its Specific Entry into Endothelial Cells J. Biol. Chem., March 21, 2003; 278(13): 11449 - 11456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Suc, S. Brunet, G. Mitchell, G.-E. Rivard, and E. Levy Oxidative tyrosylation of high density lipoproteins impairs cholesterol efflux from mouse J774 macrophages: role of scavenger receptors, classes A and B J. Cell Sci., January 1, 2003; 116(1): 89 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Major, D. E. Dove, H. Ishiguro, Y. R. Su, A. M. Brown, L. Liu, K. J. Carter, M. F. Linton, and S. Fazio Increased Cholesterol Efflux in Apolipoprotein AI (ApoAI)-Producing Macrophages as a Mechanism for Reduced Atherosclerosis in ApoAI(-/-) Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2001; 21(11): 1790 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. O'Connell and J. Genest Jr High-Density Lipoproteins and Endothelial Function Circulation, October 16, 2001; 104(16): 1978 - 1983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Jiang, V. Jha, M. Dhanabal, V. P. Sukhatme, and S. L. Alper Intracellular Ca2+ signaling in endothelial cells by the angiogenesis inhibitors endostatin and angiostatin Am J Physiol Cell Physiol, May 1, 2001; 280(5): C1140 - C1150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Stefanec Endothelial Apoptosis: Could It Have a Role in the Pathogenesis and Treatment of Disease? Chest, March 1, 2000; 117(3): 841 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M Dart and J. P.F Chin-Dusting Lipids and the endothelium Cardiovasc Res, August 1, 1999; 43(2): 308 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. H. Fidge High density lipoprotein receptors, binding proteins, and ligands J. Lipid Res., February 1, 1999; 40(2): 187 - 201. [Abstract] [Full Text]
|
|
|
|
|
|
P. Benoit, F. Emmanuel, J. M. Caillaud, L. Bassinet, G. Castro, P. Gallix, J. C. Fruchart, D. Branellec, P. Denefle, and N. Duverger Somatic Gene Transfer of Human ApoA-I Inhibits Atherosclerosis Progression in Mouse Models Circulation, January 12, 1999; 99(1): 105 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Cao, A. Girard-Globa, F. Berthezene, and P. Moulin Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q->R genetic polymorphism J. Lipid Res., January 1, 1999; 40(1): 133 - 139. [Abstract] [Full Text]
|
|
|
|
|
|
J.-R. Nofer, B. Levkau, I. Wolinska, R. Junker, M. Fobker, A. von Eckardstein, U. Seedorf, and G. Assmann Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated Lysosphingolipids J. Biol. Chem., September 7, 2001; 276(37): 34480 - 34485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kimura, K. Sato, A. Kuwabara, H. Tomura, M. Ishiwara, I. Kobayashi, M. Ui, and F. Okajima Sphingosine 1-Phosphate May Be a Major Component of Plasma Lipoproteins Responsible for the Cytoprotective Actions in Human Umbilical Vein Endothelial Cells J. Biol. Chem., August 17, 2001; 276(34): 31780 - 31785. [Abstract] [Full Text] [PDF]
|
|